Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial
Ludwig Kappos(Novartis (Switzerland)), Paul D. Crowe(Neurocrine Biosciences (United States)), Alan C. Evans(Montreal Neurological Institute and Hospital), David G. Alleva(Neurocrine Biosciences (United States)), Alex Zijdenbos(McGill University), John Castaldo, Nancy Eckert(Yale University), Paul Conlon, Dagmar Schött(University Hospital of Basel), Joseph Guarnaccia(Brown University), Dieter Pöhlau(St. Josef-Hospital), I. Brunet(Clinique de l'Yvette), Gary M. Johnson(Brown University), Gıancarlo Comı(Vita-Salute San Raffaele University), Elisabetta Giugni(Hôpital de la Timone), M. Clanet, Pierre Duquette(Centre Hospitalier de l’Université de Montréal), Christopher T. Bever(Northwestern University), Jean Pelletier(Hôpital de la Timone), Jack P. Antel(Montreal Neurological Institute and Hospital), Ernst‐Wilhelm Radue, Hillel Panitch(University of Vermont), Peter A. Calabresi(Johns Hopkins University), Eric B. Johnson(Neurocrine Biosciences (United States)), I. Berry(Centre Hospitalier Universitaire de Toulouse), Lawrence Steinman(Institute of Neurological Sciences), Volker Hoffmann(University of Maryland, Baltimore), Eleanor Katz(University of Maryland, Baltimore), Tatiana Witjas(Hôpital de la Timone), Nicholas Ling(Monash Health), Carlo Pozzilli(Ophthalmology Clinic), Carmen Lienert(University Hospital of Basel), Stefano Bastianello(Sapienza University of Rome), Alice Taksaoui(University Hospital of Basel), David Brassat(Université Toulouse III - Paul Sabatier), Amitabh Gaur(Neurocrine Biosciences (United States)), Shawki Salem(BioReliance (United States)), Pierre Bourgouin(Montreal Neurological Institute and Hospital), Alexander Rae‐Grant(Cleveland Clinic), M. Rodegher(San Raffaele University of Rome), Giancarlo Comi(Vita-Salute San Raffaele University), Joël Oger(University of British Columbia), Patrick J. Cozzone(Hôpital de la Timone), Gilles Edan, Massimo Filippi(Vita-Salute San Raffaele University), H. Przuntek, P. Mills(Brown University)
Cited by 515
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Brain development during childhood and adolescence: a longitudinal MRI study
|Nature Neuroscience|1999|5.6k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k
A clinical approach to diagnosis of autoimmune encephalitis
|The Lancet Neurology|2016|4.4k